Compare TNYA & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNYA | CURI |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.2M | 154.7M |
| IPO Year | 2021 | 2019 |
| Metric | TNYA | CURI |
|---|---|---|
| Price | $0.69 | $2.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $5.33 | ★ $5.83 |
| AVG Volume (30 Days) | ★ 2.0M | 1.6M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.36% |
| EPS Growth | ★ 54.96 | 54.17 |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $78,043,000.00 |
| Revenue This Year | N/A | $14.91 |
| Revenue Next Year | N/A | $12.91 |
| P/E Ratio | ★ N/A | $21.33 |
| Revenue Growth | N/A | ★ 9.52 |
| 52 Week Low | $0.53 | $2.30 |
| 52 Week High | $2.35 | $5.51 |
| Indicator | TNYA | CURI |
|---|---|---|
| Relative Strength Index (RSI) | 41.07 | 45.26 |
| Support Level | $0.65 | $2.32 |
| Resistance Level | $0.81 | $3.49 |
| Average True Range (ATR) | 0.03 | 0.26 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 26.13 | 5.28 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The firm's products and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, and Others. The majority of the revenue comes from the direct business and Content licensing. Geographically, the company generates the majority of its revenue from the United States.